These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1302561)

  • 21. TP53 codon 72 polymorphism and breast cancer in northern Iran.
    Kazemi M; Salehi Z; Chakosari RJ
    Oncol Res; 2009; 18(1):25-30. PubMed ID: 19911701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of p53 Pro72 homozygous genotype in non-small cell lung cancer patients.
    Boldrini L; Gisfredi S; Ursino S; Lucchi M; Greco G; Mussi A; Fontanini G
    Oncol Rep; 2008 Mar; 19(3):771-3. PubMed ID: 18288414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on the relationship between cervical cancer and p53 codon 72 polymorphism].
    Qie M; Zhang Y; Wu J
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Apr; 33(2):274-5. PubMed ID: 12575207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of the genetic polymorphism of p53 (codon 72) gene in colorectal cancer].
    Lima JM; Serafim PV; Silva ID; Forones NM
    Arq Gastroenterol; 2006; 43(1):8-13. PubMed ID: 16699611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma.
    Kim JW; Lee CG; Park YG; Kim KS; Kim IK; Sohn YW; Min HK; Lee JM; Namkoong SE
    Cancer; 2000 May; 88(9):2082-91. PubMed ID: 10813720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population.
    Pierce LM; Sivaraman L; Chang W; Lum A; Donlon T; Seifried A; Wilkens LR; Lau AF; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1199-204. PubMed ID: 11097227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between the p21 codon 31 A1 (arg) allele and lung cancer.
    Själander A; Birgander R; Rannug A; Alexandrie AK; Tornling G; Beckman G
    Hum Hered; 1996; 46(4):221-5. PubMed ID: 8807325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
    Hu Y; McDermott MP; Ahrendt SA
    Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
    Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians.
    David-Beabes GL; London SJ
    Lung Cancer; 2001 Dec; 34(3):333-9. PubMed ID: 11714530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
    Bhattacharya P; Sengupta S
    Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes.
    Papadakis ED; Soulitzis N; Spandidos DA
    Br J Cancer; 2002 Oct; 87(9):1013-8. PubMed ID: 12434294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency.
    Govan VA; Loubser S; Saleh D; Hoffman M; Williamson AL
    Int J Immunogenet; 2007 Jun; 34(3):213-7. PubMed ID: 17504512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types.
    Gao WM; Mady HH; Yu GY; Siegfried JM; Luketich JD; Melhem MF; Keohavong P
    Lung Cancer; 2003 May; 40(2):141-50. PubMed ID: 12711114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California.
    London SJ; Daly AK; Cooper J; Navidi WC; Carpenter CL; Idle JR
    J Natl Cancer Inst; 1995 Aug; 87(16):1246-53. PubMed ID: 7563171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [p53 gene codon 72 polymorphism and susceptibility to keloid in Chinese population].
    Zhuo Y; Gao J; Luo S; Zeng W; Hu Z; Lu F; Zhao Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Jan; 19(1):28-30. PubMed ID: 15704837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Association of p53 gene polymorphism with susceptibility to ovarian cancer].
    Kang S; Duan LH; Zhang JH; Guo W; Wang N; Li Y
    Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):754-8. PubMed ID: 15634502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.
    Yamaguchi K; Sugano K; Fukayama N; Nakashima Y; Saotome K; Yokoyama T; Yokota T; Ohkura H
    Am J Gastroenterol; 1997 Feb; 92(2):307-12. PubMed ID: 9040212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer.
    Fisher MJ; Virmani AK; Wu L; Aplenc R; Harper JC; Powell SM; Rebbeck TR; Sidransky D; Gazdar AF; El-Deiry WS
    Clin Cancer Res; 2001 Jun; 7(6):1688-97. PubMed ID: 11410508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of evidence of association of p21WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan.
    Shih CM; Lin PT; Wang HC; Huang WC; Wang YC
    Jpn J Cancer Res; 2000 Jan; 91(1):9-15. PubMed ID: 10744039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.